 |
 |
 |
|
 The Iris Stat Spin Express 4
The StatSpin Express 4, high speed horizontal centrifuge provides faster turnaround time and greater productivity for your "lean" laboratory. Place it next to any STAT analyzer and serum or plasma gel tubes are ready in just minutes. Learn more...
|
|
 |
|
 |
|
| Featured Article |
|
|
 |
No More “Death By Lecture” for Annual OSHA Retraining
If you’re responsible for annual OSHA retraining for your facility and look forward to it as much as you do a root canal, read on to learn about other options that will put your fears to rest and also provide a great, effective learning experience for your staff.
more... |
| |
|
| News |
|
|
Senate Passes Genetic Discrimination Bill
WASHINGTON (AP) — People learning through genetic testing that they might be susceptible to devastating diseases wouldn't also have to worry about losing their jobs or their health insurance under ...
more... |
| |
Prostate-Specific Antigen at or Before Age 50 as a Predictor of Advanced Prostate Cancer Diagnosed up to 25 Years Later: A Case-Control Study
The group of Dr. Lilja have previously shown that a single PSA measurement at or before age 50 is a strong predictor of prostate cancer (CaP) occurring up to 25 years later. In the online version of ...
more... |
| |
Pathwork® Diagnostics Launches Genomics-Based Test for Hard-To-Identify Tumors Through Its Clia-Certified Laboratory
Pathwork Diagnostics, Inc., a genomics-based diagnostics company focused on oncology, today announced the launch of the Pathwork Tissue of Origin Test through its CLIA-certified Pathwork® ...
more... |
| |
Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement
Agendia BV, a world leader in the rapidly evolving field of molecular diagnostics, and Agilent Technologies, Inc. (NYSE: A), today announced terms under which they intend to collaborate to develop ...
more... |
| |
OHSU Cancer Institute Researcher Identifies Protein That Helps Predict Prostate Cancer Survival
An Oregon Health & Science University Cancer Institute researcher has identified a protein that is a strong indicator of survival for men with advanced prostate cancer. The C-reactive protein, also ...
more... |
| |
Thousands of Volunteers Needed to Help Bring Cure for Cancer Closer
Researchers, who are in the process of developing a blood test that may diagnose breast cancer up to four years earlier than a mammogram, need the help of thousands of people living in the East ...
more... |
| |
Study Finds Patients Overestimate Cancer Screening History
A new American Cancer Society study finds female African American patients tend to overestimate their level of cancer screening, indicating that current estimates of screening based on self-reported ...
more... |
| |
Response Biomedical Receives U.S. FDA 510(k) Market Clearance of Rapid Influenza A+B Test
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that it received a U.S. Food and Drug Administration (FDA) 510(k) clearance to market a rapid Influenza A+B test (Flu A+B ...
more... |
| |
Dermtech Presents Data Supporting Use of Noninvasive Genomic Assay to Detect Early-Stage Melanoma
DermTech, a biotechnology company developing molecular diagnostics for the early detection of melanoma and other diseases, will present data at the American Association of Cancer Research on its ...
more... |
| |
Saliva Can Help Diagnose Heart Attack, Study Shows
Early diagnosis of a heart attack may now be possible using only a few drops of saliva and a new nano-bio-chip, a multi-institutional team led by researchers at The University of Texas at Austin ...
more... |
| |
| For More Diagnostics News, go here |
| |
|
| New Products |
|
|
 |
Ariol® Pathology Imaging Analysis System
Genetix
Ariol is a high throughput automated image analysis system for the quantification of biomarkers on microscope slides in research, clinical, pharmaceutical, genomic, and proteomic applications. Capable of both brightfield and fluorescent imaging, it rapidly scans and quantitates IHC, FISH, immunofluorescence, micrometastasis, angiogenesis, DNA Ploidy, and tissue microarray slides. Ariol is FDA cleared for in vitro diagnostic use of HER-2/neu, ER, and PR IHC, PathVysion® and the detection of micrometastases in bone marrow.
more... |
| |
| For more of the latest in Medical products and services, go here |
| |
|
| Product Showcase |
|
|
 |
Access® 2 Immunoassay System
Beckman Coulter, Inc.
With an intuitive operator interface, enhanced sample handling and innovative menu, the state-of-the-art Access 2 system delivers new levels of laboratory efficiency, standardization and cost effectiveness. A broad menu of high quality assays from Beckman Coulter, plus new, productivity-enhancing features on the Access 2 offer laboratories a flexible option for immunoassay testing.
more... |
| |
|
| Events |
|
|
The 13th Annual Executive War College
May 13 - 14, 2008
Intercontinental Hotel in Miami, Florida
With each year, the reputation of the Executive War College on Laboratory and Pathology Management increases. It is a unique two-day program with a single objective: to help laboratory administrators and pathologists learn practical methods for improving the organizational performance and financial success of their laboratories.
more... |
| |
| For more Events, go here |
| | | |
